- Lobbying
- Lobbying by TAP Pharmaceuticals, Inc.
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Gwen E. Mellor | Intern, Office of Senator Joseph Biden |
Kate McAuliffe Smith | Assoc.Coun House Minority Ldr Richard Gephardt |
Reid P.F. Stuntz | Stff Dir/Chf Coun, Min.Stff Dir, Chf Coun (cont) En & Comm |
Robert D. Kyle | Prin Assoc Dir, OMB; Sp. Asst to Pres. (cont) NEC Chf Int'l Trade Coun, Sen.Fin.Comm |
Beth L. Roberts | n/a |
John Edward Porter | n/a |
Kathleen M. Smith | n/a |
Sheree R. Kanner | n/a |
Michael J. Bell | n/a |
Cole Finegan | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Termination
Lobbying Issues
Agencies Lobbied
Type of Issue
Registration
Issue(s) they said they’d lobby about: Least costly alternative.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate